Shanghai Haohai Biological Tech Co (688366) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Haohai Biological Tech Co (688366) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥109.13 Million ≈ $15.97 Million USD) by net assets (CN¥5.88 Billion ≈ $861.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Shanghai Haohai Biological Tech Co for the company's overall valuation and market capitalisation.
Shanghai Haohai Biological Tech Co - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Shanghai Haohai Biological Tech Co's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shanghai Haohai Biological Tech Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Haohai Biological Tech Co ranked by their cash flow conversion efficiency. Explore Shanghai Haohai Biological Tech Co earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
HMT Limited
NSE:HMT
|
-0.004x |
|
Foschini Group Ltd
JSE:TFG
|
0.256x |
|
Guangzhou Boji Medical and Biotechnological Co Ltd
SHE:300404
|
-0.007x |
|
Truworths International Ltd
JSE:TRU
|
0.144x |
|
Crossamerica Partners LP
NYSE:CAPL
|
-0.355x |
|
Wave Life Sciences Ltd
NASDAQ:WVE
|
-0.116x |
|
TEAMVIEWER USP ADR 2/1 ON
F:TMV1
|
0.803x |
|
PPHE Hotel Group Ltd
F:32P
|
0.024x |
Annual Cash Flow Conversion Efficiency for Shanghai Haohai Biological Tech Co (2012–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Haohai Biological Tech Co from 2012 to 2024. View 688366 live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥5.92 Billion ≈ $865.85 Million |
CN¥648.57 Million ≈ $94.91 Million |
0.110x | +3.96% |
| 2023-12-31 | CN¥6.02 Billion ≈ $880.52 Million |
CN¥634.45 Million ≈ $92.84 Million |
0.105x | +169.06% |
| 2022-12-31 | CN¥5.90 Billion ≈ $863.70 Million |
CN¥231.30 Million ≈ $33.85 Million |
0.039x | -30.62% |
| 2021-12-31 | CN¥6.06 Billion ≈ $886.81 Million |
CN¥342.29 Million ≈ $50.09 Million |
0.056x | +23.58% |
| 2020-12-31 | CN¥5.73 Billion ≈ $839.10 Million |
CN¥262.07 Million ≈ $38.35 Million |
0.046x | -25.95% |
| 2019-12-31 | CN¥5.65 Billion ≈ $827.26 Million |
CN¥348.91 Million ≈ $51.06 Million |
0.062x | -39.50% |
| 2018-12-31 | CN¥3.84 Billion ≈ $561.25 Million |
CN¥391.28 Million ≈ $57.26 Million |
0.102x | +0.12% |
| 2017-12-31 | CN¥3.37 Billion ≈ $492.65 Million |
CN¥343.06 Million ≈ $50.20 Million |
0.102x | +19.56% |
| 2016-12-31 | CN¥2.99 Billion ≈ $436.93 Million |
CN¥254.49 Million ≈ $37.24 Million |
0.085x | -15.39% |
| 2015-12-31 | CN¥2.67 Billion ≈ $390.04 Million |
CN¥268.51 Million ≈ $39.29 Million |
0.101x | -57.85% |
| 2014-12-31 | CN¥594.16 Million ≈ $86.94 Million |
CN¥141.99 Million ≈ $20.78 Million |
0.239x | -11.33% |
| 2013-12-31 | CN¥545.05 Million ≈ $79.76 Million |
CN¥146.91 Million ≈ $21.50 Million |
0.270x | -10.48% |
| 2012-12-31 | CN¥393.33 Million ≈ $57.56 Million |
CN¥118.42 Million ≈ $17.33 Million |
0.301x | -- |
About Shanghai Haohai Biological Tech Co
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. It offers ophthalmology products consist of intraocular lens, medical sodium hyaluronate gel, and lubricant eye drop. The company also offers sodium hyaluronate injection, medical chitosan, medical sodium hyal… Read more